持田製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/07/25 | 3,380 | 3,480 | 3,380 | 3,460 | +35 | +1% | 41,900 |
| 2024/07/24 | 3,400 | 3,455 | 3,400 | 3,425 | -15 | -0.4% | 17,100 |
| 2024/07/23 | 3,385 | 3,460 | 3,385 | 3,440 | +55 | +1.6% | 26,100 |
| 2024/07/22 | 3,425 | 3,425 | 3,375 | 3,385 | -75 | -2.2% | 26,500 |
| 2024/07/19 | 3,465 | 3,485 | 3,420 | 3,460 | -5 | -0.1% | 20,100 |
| 2024/07/18 | 3,405 | 3,515 | 3,375 | 3,465 | +35 | +1% | 38,600 |
| 2024/07/17 | 3,375 | 3,430 | 3,375 | 3,430 | +65 | +1.9% | 28,600 |
| 2024/07/16 | 3,370 | 3,420 | 3,345 | 3,365 | -5 | -0.1% | 61,400 |
| 2024/07/12 | 3,305 | 3,370 | 3,305 | 3,370 | +45 | +1.4% | 32,600 |
| 2024/07/11 | 3,330 | 3,345 | 3,305 | 3,325 | +25 | +0.8% | 35,100 |
| 2024/07/10 | 3,330 | 3,330 | 3,280 | 3,300 | -50 | -1.5% | 52,200 |
| 2024/07/09 | 3,295 | 3,370 | 3,295 | 3,350 | +60 | +1.8% | 44,500 |
| 2024/07/08 | 3,300 | 3,330 | 3,280 | 3,290 | ±0 | ±0% | 38,700 |
| 2024/07/05 | 3,285 | 3,330 | 3,285 | 3,290 | +5 | +0.2% | 30,100 |
| 2024/07/04 | 3,285 | 3,305 | 3,240 | 3,285 | +30 | +0.9% | 35,200 |
| 2024/07/03 | 3,195 | 3,260 | 3,195 | 3,255 | +40 | +1.2% | 38,700 |
| 2024/07/02 | 3,150 | 3,235 | 3,150 | 3,215 | +65 | +2.1% | 59,400 |
| 2024/07/01 | 3,110 | 3,155 | 3,110 | 3,150 | +35 | +1.1% | 27,600 |
| 2024/06/28 | 3,080 | 3,115 | 3,080 | 3,115 | +15 | +0.5% | 25,000 |
| 2024/06/27 | 3,115 | 3,120 | 3,080 | 3,100 | -30 | -1% | 36,500 |
| 2024/06/26 | 3,120 | 3,145 | 3,100 | 3,130 | +30 | +1% | 32,400 |
| 2024/06/25 | 3,085 | 3,115 | 3,060 | 3,100 | +15 | +0.5% | 43,000 |
| 2024/06/24 | 3,075 | 3,115 | 3,070 | 3,085 | +15 | +0.5% | 34,500 |
| 2024/06/21 | 3,040 | 3,085 | 3,025 | 3,070 | +40 | +1.3% | 63,000 |
| 2024/06/20 | 3,015 | 3,040 | 3,010 | 3,030 | +15 | +0.5% | 24,700 |
| 2024/06/19 | 2,989 | 3,015 | 2,988 | 3,015 | +25 | +0.8% | 19,500 |
| 2024/06/18 | 2,987 | 3,005 | 2,979 | 2,990 | +18 | +0.6% | 30,300 |
| 2024/06/17 | 2,903 | 2,972 | 2,901 | 2,972 | +50 | +1.7% | 35,500 |
| 2024/06/14 | 2,863 | 2,935 | 2,863 | 2,922 | +52 | +1.8% | 60,800 |
| 2024/06/13 | 2,963 | 2,963 | 2,870 | 2,870 | -113 | -3.8% | 83,700 |
| 2024/06/12 | 3,025 | 3,040 | 2,973 | 2,983 | -97 | -3.1% | 56,300 |
| 2024/06/11 | 3,115 | 3,120 | 3,080 | 3,080 | -30 | -1% | 20,500 |
| 2024/06/10 | 3,050 | 3,115 | 3,050 | 3,110 | +60 | +2% | 19,800 |
| 2024/06/07 | 3,035 | 3,060 | 3,030 | 3,050 | +5 | +0.2% | 16,000 |
| 2024/06/06 | 3,075 | 3,090 | 3,035 | 3,045 | -30 | -1% | 18,700 |
| 2024/06/05 | 3,065 | 3,085 | 3,045 | 3,075 | +15 | +0.5% | 35,100 |
| 2024/06/04 | 3,030 | 3,090 | 3,030 | 3,060 | +25 | +0.8% | 35,700 |
| 2024/06/03 | 3,030 | 3,060 | 3,025 | 3,035 | +5 | +0.2% | 30,800 |
| 2024/05/31 | 2,975 | 3,035 | 2,961 | 3,030 | +79 | +2.7% | 71,300 |
| 2024/05/30 | 2,921 | 2,965 | 2,902 | 2,951 | +26 | +0.9% | 29,500 |
| 2024/05/29 | 2,928 | 2,945 | 2,924 | 2,925 | -3 | -0.1% | 27,000 |
| 2024/05/28 | 2,950 | 2,957 | 2,928 | 2,928 | -30 | -1% | 26,500 |
| 2024/05/27 | 2,966 | 2,966 | 2,930 | 2,958 | +3 | +0.1% | 35,000 |
| 2024/05/24 | 2,945 | 2,966 | 2,931 | 2,955 | -2 | -0.1% | 30,900 |
| 2024/05/23 | 2,989 | 2,989 | 2,941 | 2,957 | -38 | -1.3% | 35,100 |
| 2024/05/22 | 3,030 | 3,030 | 2,991 | 2,995 | -10 | -0.3% | 44,000 |
| 2024/05/21 | 3,040 | 3,060 | 3,005 | 3,005 | -40 | -1.3% | 36,700 |
| 2024/05/20 | 3,030 | 3,060 | 3,030 | 3,045 | -10 | -0.3% | 35,400 |
| 2024/05/17 | 3,055 | 3,055 | 3,030 | 3,055 | ±0 | ±0% | 13,900 |
| 2024/05/16 | 3,060 | 3,065 | 3,025 | 3,055 | ±0 | ±0% | 28,900 |
201～
250
件表示中 / 3705件
類似銘柄と比較する
現在ご覧いただいている「持田薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 持田薬 | 297,600円 | +5.1% | -7.0% | 2.69% | 19.54倍 | 0.81倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
| ジーエヌアイ | 297,100円 | +21.7% | +999.9% | 0.00% | 12.45倍 | 4.12倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
| ゼリア新薬 | 213,700円 | +3.1% | -6.5% | 2.25% | 9.92倍 | 1.05倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| 杏林製薬 | 146,000円 | -2.4% | -52.3% | 3.90% | 17.47倍 | 0.62倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
| 栄研化 | 200,000円 | +4.1% | -3.1% | 2.90% | 17.54倍 | 1.53倍 |
|
臨床検査薬大手。便潜血検査試薬（ＦＩＴ）はシェア７割。尿検査（ウロ）、遺伝子検査も育成 |
市場注目の銘柄
チャート関連のコラム
